Previous studies [Klee, Milligan, Simonds & Tocque (1985) Mol. Aspects Cell Regul. 4,[117][118][119][120][121][122][123][124][125][126][127][128][129] have shown that cholera toxin treatment can result in a decrease in the maximal effectiveness of agonists which function to inhibit adenylate cyclase These data have been used as evidence to suggest a functional interaction between G8 and 'G1'. The results provided herein demonstrate that such effects of the toxin can be explained adequately by a decrease in the number of receptors that function to produce inhibition of adenylate cyclase.
INTRODUCTION
The neuroblastoma x glioma hybrid cell line NG108-15 has been used widely to examine transmembrane signalling cascades, as it expresses a wide range of receptors able to either stimulate or inhibit adenylate cyclase [1] . One of the most studied receptors on these cells is an opioid receptor of the a subtype [2] [3] [4] . Agonist activation of this receptor results in both stimulation of highaffinity GTPase activity [3] and inhibition of adenylate cyclase [4] . Pretreatment of the cells with pertussis toxin attenuates the effects of opioids on both of the these enzymic activities [5] [6] [7] and thus demonstrates that the guanine-nucleotide-binding protein (G-protein) that couples the a opioid receptor to adenylate cyclase is a substrate for pertussis toxin-catalysed ADP- ribosylation. We have recently demonstrated, by using immunological probes able to interfere with the coupling of receptors and G-proteins, that this G-protein ('G,') is the product of the G12a gene [8] .
Whereas pertussis toxin is able to catalyse the ADP-ribosylation of the a. subunits of a considerable number of G-proteins, including G 1, G12, Gi3 and G., cholera toxin has a much more limited range of G-protein substrates. Apart from forms of transducin and Golf (a G-protein which regulates odorant stimulation of adenylate cyclase in olfactory neuroepithelium) [9] , which are expressed in only very limited tissue locations, the only well-characterized G-protein that is modified by cholera toxin-catalysed ADP-ribosylation is the stimulatory G-protein (Ge) of the adenylate cyclase cascade [10] .
Cholera toxin can catalyse the ADP-ribosylation of the ac subunits of a number of G-proteins which are traditionally viewed as being substrates only for pertussis toxin-catalysed ADP-ribosylation, but this can be achieved only when using cell membranes under artificial conditions which produce a state of the G-protein that does not have either GDP or GTP in the nucleotide-binding pocket [10] . These conditions are unlikely to occur in a whole cell. Based on the known activity of cholera toxin and the inability of cholera toxin treatment of whole cells to produce covalent modification of pertussis toxin-sensitive Gproteins, it was therefore somewhat surprising that cholera toxin treatment of NG108-15 cells was observed to produce a decrease in the maximal degree of opioid-mediated inhibition of adenylate cyclase [7] . The present paper examines the mechanism of this effect of cholera toxin. We demonstrate that it can be accounted for by a down-regulation of the opioid receptor by cholera toxin. Similar effects were noted for the a2B-adrenergic receptor on these cells, which also functions to produce an inhibition of adenylate cyclase. tTo whom correspondence should be addressed.
MATERIALS AND METHODS
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The antisera were generated in New Zealand White Rabbits using a conjugate of the synthetic peptide and keyhole limpet haemocyanin as detailed [11, 12] . Gila and G12a have identical C-terminal decapeptides, and thus antiserum AS7 identifies each of these polypeptides equally. Transducin a is also identified by antiserum AS7, but as this G-protein is restricted in distribution to photoreceptor-containing tissues then the antiserum can be used as a probe for Gil or Gi2 in all other locations. NG108-15 cells express high levels of Gi2 but do not express detectable levels of Gil [8] .
Antiserum 13B can be demonstrated to display weak cross-reactivity with Goa from rat brain; however, the amounts of Goa expressed in NG108-15 cells are sufficiently low that we have been unable to identify Goa in membranes of these cells with this antiserum (results not shown). See [26] for detailed characterization of the reactivity of antiserum 13B against Gi3a. Comparisons of degrees of immunological staining and thus of the relative levels of G-protein subunits in membrane fractions were achieved either densitometrically as detailed in [27] or after exposure of the developed immunoblots to .25I-labelled anti-rabbit IgG as detailed in [13] . Cell culture Neuroblastoma x glioma hybrid NG108-15 cells were grown in tissue culture as described previously [8] , except that foetal bovine serum was replaced by controlled process serum replacement-type 3 (CPSR-3) hybri-max (Sigma), as this has less potential batch-to-batch variation than foetal bovine serum. Cells were harvested when some 80 % confluent, and membrane fractions were prepared as in [8] . In some cases the cells were treated with cholera toxin (up to I ,ug/ml, 16 h) before harvest.
Membranes were stored at -70°C before use.
Immunological studies
The generation and specificities of the antisera used in this study are defined in Table 1 3 h. Removal of the secondary antiserum was followed by the same series of extensive washes of the nitrocellulose, as detailed for after removal of the primary antiserum [12] . o-Dianisidine hydrochloride (Sigma) was employed as the substrate for detection of the antibody complex, as previously described [8] .
Quantification of immunoblots
In a number of cases the developed immunoblots were subsequently treated with an 125I-labelled donkey anti-rabbit IgG (Amersham International) (0.1 ,uCi/ml) in 1 % gelatin/TBS/0.2 % NP40 for 2 h. After extensive washing with TBS/0.2 % NP40 and then TBS the blot was air-dried and the coloured bands were excised, and radioactivity was assessed in a y-radiation counter. In such cases preliminary experiments were performed to assess the range of linearity of the assay for each antiserum (see [13] for an example). Such experiments involved immunoblotting and subsequent treatment of various amounts of NG108-15 membranes with 125I-labelled anti-rabbit IgG as described above. Amounts of membranes used to assess the effects of cholera toxin treatment on levels of the various G-proteins were, in all cases, within the observed linear region.
Adenylate cyclase assays
Forskolin (10 M)-amplified adenylate cyclase activities and opioid peptide and a2-adrenergic modulation of this activity were measured as described [8] . terminated by rapid filtration through Whatman GF/C filters followed by three washes of the filter with ice-cold buffer B (5 ml). Specific binding data were manipulated according to Scatchard [18] . The binding of [3H]yohimbine to a2-adrenergic receptors was assessed in similar fashion. Non-specific binding of [3H]yohimbine was assessed in the presence of 100 /uM-noradrenaline.
RESULTS
The synthetic enkephalin DADLE stimulated high-affinity GTPase activity in membranes of neuroblastoma x glioma NG108-15 cells in a dose-dependent manner (Fig. 1) . Maximal stimulation, which in these experiments was 11. 16 h) demonstrated that essentially maximal effects of the toxin on DADLE-stimulation of high-affinity GTPase activity were produced by 100 ng of cholera toxin/ml, and that halfmaximal effects were produced at some 3 ng/ml (Fig. 2) . After pretreatment of NG108-15 cells with cholera toxin (lug/ml, 16 h) the basal adenylate cyclase activity in the membranes of these cells was only slightly higher than that in membranes from untreated cells (Table 2) . We have previously noted this to be so and have demonstrated that it is a reflection of cholera toxininduced down-regulation of most of the cellular levels of G,a over this time period. As with opioid-stimulation of high-affinity GTPase activity, DADLE-mediated inhibition of forskolin (10 /sM)-amplified adenylate cyclase activity was also lowered substantially in membranes from the cholera toxin-treated cells (maximal inhibition 21 %) compared with those from untreated cells (maximal inhibition 35 %) ( Table 2 ).
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As effects of both opioid and a2-adrenergic agonists were decreased in membranes from cholera toxin-pretreated cells, we examined the levels and activity of G,2a under each condition, as we have recently demonstrated that opioid regulation of adenylate cyclase is controlled by this G-protein [8] . A decrease in either of these parameters might be expected to produce the observed results.
Immunoblotting of membranes derived from NG108-15 cells treated with various concentrations of cholera toxin (0-1 ,ug/ml) for 16 h with antiserum AS7 (which, of the various G-proteins expressed by these cells, identifies only G,2a [8] ) indicated no decrease in membrane-associated levels of this polypeptide (Fig.   3b ). NG108-15 cells also express both G,3a and G.a. Levels of these polypeptides were also not decreased by pretreatment of the cells with cholera toxin (1 ,ug/ml) ( Table 4) . By contrast, as we have previously noted, chronic exposure of cells to cholera toxin produced a marked decrease in membrane-associated levels [18] . of G,a (Fig. 3a) , as assessed by immunoblotting membranes from these cells with antiserum CS1. Indeed, at concentrations of cholera toxin above 10 ng/ml used for pretreatment of the cells it was difficult to detect G,a immunologically, which in these cells is primarily expressed as a 44 kDa polypeptide, in the membrane fraction. We have previously shown that antibody CSl identifies equally well both ADP-ribosylated and non-modified forms of Gsa [19] .
To assess if the activity of G, was decreased by cholera toxin pretreatment of the cells, we measured forskolin-amplified adenylate cyclase activity in the presence of low concentrations of the poorly hydrolysed analogue of GTP, Gpp[NH]p, which has been demonstrated to display greater affinity forGi than for G., and hence can be used to selectively activate the inhibitory arm of adenylate cyclase [15, 16] . In membranes from both untreated and cholera toxin-treated cells, Gpp[NH]p was able to produce maximal inhibition of forskolin-activated adenylate cyclase at some 3 nm, and in both cases the degree of inhibition at this concentration was some 15 % (Fig. 4 ). As such we were able to conclude that the intrinsic activity ofGi was not attenuated in membrane preparations from cells which had been pretreated with cholera toxin.
In the presence of 20 mM-Mg2", saturation analysis of 4 nM) , however, was the same as in membranes from the untreated cells (Fig. 5) .
The decrease in 8 opioid receptor levels in membranes of NG108-15 cells produced by cholera toxin treatment over a 16 h period was half-maximal when 2.5 ng of toxin/ml was used, and was essentially maximal at 100 ng/ml (Fig. 6a ). An equivalent Table 3 ). The concentration of cholera toxin producing half-maximal loss of a2-adrenergic receptors was approx. 3 ng/ml (Fig. 6b) .
DISCUSSION
Cholera toxin, because of its ability to catalyse the mono-ADP-ribosylation of the a subunit(s) of Gr, has been of major importance in attempts to elucidate the mechanistic details of receptor regulation of the stimulation of adenylate cyclase.
Although the persistent activation of G, and hence of adenylate cyclase, produced by this toxin is understood to result from an inhibition of the GTPase reaction which would normally function to de-activate Gsa [20] , it has recently become apparent that the effects of cholera toxin treatment of cells on the adenylate cyclase cascade are not limited to this single manifestation. In terms of the stimulatory arm, cholera toxin-catalysed ADP-ribosylation of Gsa leads to a down-regulation of steady-state levels of this polypeptide at the plasma membrane [19, 21] . Cholera toxin treatment of cells has also been noted to alter the effectiveness of receptor regulation of the inhibition of adenylate cyclase [7] , but it has been uncertain at which level this effect is produced. In the present paper we demonstrate that a cholera toxin-mediated decrease in the function of receptors which produce inhibition of adenylate cyclase in NG108-15 cells can be accounted for by a cholera toxin-induced loss of plasma membrane receptors. After treatment of NG108-15 cells with cholera toxin (up to1 /ag/ml, 16 h) levels of the a opioid receptor were lowered by approx. 350% (Fig. 6) receptor activation of the G-protein, was identical in untreated and cholera toxin-treated cells, even though the maximal effect of the opioid agonist was decreased by 35% (Fig. 1) , suggesting that the effect was produced at the level of receptor number.
A similar decrease in degree both of the levels of the a2-adrenergic receptor, as assessed by the binding capacity for the a2-adrenergic antagonist [3H]yohimbine, and of the ability of the a2-adrenergic-selective agonist UK 14304 to inhibit forskolinamplified adenylate cyclase activity (Table 3) , indicated further that the effect of cholera toxin on the inhibitory control of adenylate cyclase was not limited to the opioid receptor.
A decrease in the ability of both opioid peptides and an a2-adrenergic agonist to inhibit adenylate cyclase could potentially be produced if either the absolute levels or the activity of G1 were lowered by cholera toxin treatment, and indeed this could act as a convenient site for the induction of a heterologous form of control of the inhibition of adenylate cyclase. Such a scenario has recently been reported to occur in rat adipocytes in tissue culture, where incubation of the cells with an adenosine Al receptor agonist produced marked down-regulation of each of Gil, G12 and G,3, but not of G. [22] . Such down-regulation is accompanied by the development of a heterologous form of desensitization at receptors which produce inhibition of adenylate cyclase (A. Green, G. Milligan & S. E. Belt, unpublished work).
We have recently taken advantage of the ability of antisera directed against the C-terminal regions of the a subunits of various G-proteins to prevent contact of the G-protein with receptors in order to demonstrate that the G2a gene product represents the true inhibitory G-protein of the adenylate cyclase cascade, at least in NG108-15 cells [8] . A similar conclusion as to the molecular nature of G1 has been reached by Simonds et al. [23] in studies on human platelets. By immunoblotting membranes of NG108-15 cells, which had been treated with various concentrations of cholera toxin, with an antiserum (AS7) which in these cells identifies only G12a, we have demonstrated that steady-state levels of G12a were not decreased by cholera toxin treatment (Fig. 3) . Further, no alteration in the mobility of Gi2 in SDS/PAGE was observed after cholera toxin treatment (Fig. 3) . This provides supportive evidence that cholera toxin treatment did not produce ADP-ribosylation of G,2a, as we have previously shown that the addition of ADP-ribose to a G-protein a subunit decreases its mobility through SDS/PAGE [11] , presumably due to the extra molecular mass provided by the ADP-ribose. We have also demonstrated that levels of the other pertussis toxin-sensitive G-proteins expressed by these cells, G13a and G,a, were not decreased by cholera toxin treatment of the cells (Table 4 higher affinity for Gi than for G, [15, 16] . As (Fig. 4) Effects of cholera toxin treatment of cells on levels of various receptors have previously been recorded. The decrease in the ability of vasopressin to stimulate production of inositol phosphates in L6 skeletal myoblasts [24] and of both vasopressin and angiotensin to do the same in renal glomerulosa cells [25] has been demonstrated to be due to a cyclic AMP-dependent downregulation of the relevant receptor, presumably subsequent to activation of protein kinase A. Indeed, it is likely that the effects of cholera toxin on cellular levels of 6 opioid and 2-adrenergic receptors in NG108-15 cells are produced in a similar manner and are dependent upon the generation of cyclic AMP. Stimulation of cyclic AMP production in NG108-15 cells either by direct activation of adenylate cyclase with forskolin or by activating a prostanoid receptor on these cells with prostaglandin E1 also produces a decrease in the level of the 6 receptor number is related to phosphorylation of the receptor or is produced at some other level. As the 6 opioid receptor has not yet been cloned and suitable antisera are not available, information relating to this point is unlikely to be obtained easily. The only alteration in levels, activities or interactions of the components of the inhibitory arm of adenylate cyclase that we have been able to measure after cholera toxin treatment of NG108-15 cells is the number of receptor-binding sites detectable in the membrane. We must conclude that the decreased maximal activity of opioid agonists in stimulating high-affinity GTPase activity, and subsequently in inhibiting adenylate cyclase, which is observed subsequent to cholera toxin treatment of NG108-15 cells is due entirely to the decrease in opioid receptor number.
